Enterococcus faecium BM4102 was resistant to macrolide-lincosamide-streptogramin B-type (MLS) antibiotics; tetracycline-minocycline; and high levels of kanamycin, neomycin, tobramycin, and dibekacin but not gentamicin. This aminoglycoside resistance phenotype is new in enterococci. The genes conferring resistance to aminoglycosides and MLS antibiotics in this strain were carried on a plasmid, pIP810, that was selftransferable to other Enterococcus strains. Resistance to tobramycin and structurally related aminoglycosides, kanamycin, neomycin, and dibekacin, was due to synthesis of a 4',4"-aminoglycoside nucleotidyltransferase. Homology was detected by hybridization between pIP810 DNA and a probe specific for a gene encoding an enzyme with identical site specificity in staphylococci. The bacteriostatic activity of amikacin apparently was not affected by the presence of the enzyme, although it was modified in vitro. However, the bactericidal activity of amikacin and the synergism of this aminoglycoside with penicillin were abolished.
Enterococci and streptococci are naturally resistant to low levels of aminoglycosides (with MICs of 4 to 250 ,ug/ml) (30) . Enterococci are less susceptible than streptococci to penicillin (15) . However, combinations of penicillin with aminoglycosides usually display bactericidal synergy against clinical isolates of enterococci (14, 27, 32) . Synergism is abolished in isolates with high-level resistance to aminoglycosides (MICs, .2,000 p,g/ml) (12, 34 ; R. Leclercq, S.
Dutka-Malen, A. Brisson-Noel, C. Molinas, E. Derlot, M. Arthur, and P. Courvalin, Rev. Infect. Dis., in press). Resistance to high levels of aminoglycosides is generally due to acquisition of genes encoding aminoglycoside-modifying enzymes (3) . The resistance determinants are most often part of self-transferable or mobilizable plasmids (7, 13, 25) or of conjugative transposons (5) and have spread in recent years in numerous species of streptococci and enterococci (Leclercq et al., in press).
High-level resistance to tobramycin not associated with resistance to gentamicin has, to our knowledge, not been detected in enterococci-streptococci. In this study, we describe an Enterococcus faecium strain that is resistant to high levels (>1,000 ,ug/ml) of tobramycin and susceptible to gentamicin. The plasmid-borne resistance gene was compared with that gene (20) which is responsible for a similar phenotype in Staphylococcus aureus (16) . The consequences of the presence of the enzyme on the bacteriostatic and bactericidal activities of aminoglycosides alone or in combination with penicillin against the bacterial host were determined.
MATERIALS AND METHODS
Bacterial strains. The properties of the strains used in this study are listed in Table 1 . E. faecium BM4102 was isolated in France in 1985 from a sputum sample. E. faecium BM4105 is a wild-type strain that is susceptible to antibiotics. Both isolates produced low levels of 6'-aminoglycoside acetyltransferase, which is generally present in strains of E. faecium (21, 33) . They were identified as enterococci by Gram staining; absence of catalase; inability to produce gas; presence of Lancefield antigen group D; and growth on 40% bile, in 6.5% sodium chloride, in 0.1% methylene blue, and at pH 9.6. Species identification (9, 24) was based on the absence of potassium tellurite reduction and tests for acid production from 50 carbohydrates in API 50 CH galleries of tests (API System, La Balme-les-Grottes, France).
Media. Brain heart infusion broth and agar (Difco Laboratories, Detroit, Mich.) were used. Susceptibility tests were done in Mueller-Hinton broth and agar (Diagnostics Pasteur, Marnes-la-Coquette, France). All incubations were done at 370C.
Antibiotic susceptibility testing. The method of Steers et al. (28) , with 104 CFU per spot, was used to determine the MICs of antibiotics in solid niedium. The MICs in liquid medium were determined with an inoculum of 105 to 106 CFU/ml, and the MBCs were at the 99.9% killing level. Time-kill curves were determined with an inoculum of 107 CFU/ml and 20 ,ug of penicillin, amikacin, or kanamycin per ml and 4 p,g of tobramycin per ml. The concentrations of aminoglycosides were below the MICs for the strains studied and did not affect their growth. Synergy was defined as an increase in killing by the association after 24 h equal to or greater than 100-fold compared with that of the most effective antibiotic alone.
Transfer of antibiotic resistance traits. Mating on filters was performed as described previously (31) . The antibiotic concentrations for selection of transconjugants were as follows: erythromycin, 10 ,ug/ml; and streptomycin and tobramycin, 1,000 jig/ml.
Preparation of DNA and agarose gel electrophoresis. Preparation of high-molecular-weight total DNA (8) and purification of plasmid DNA (6) were done as described previously. The DNA restriction fragments were separated by electrophoresis in horizontal slab gels (20 by 20 by 0.7 cm) containing 0.8% agarose type II or type VII (Sigma Chemical Co., St. Louis, Mo.). Fragments were extracted from lowtemperature-gelling agarose type VII as described previously (18) .
Assay for aminoglycoside-modifying enzymes. Bacterial ex- a Tra+, Self-transferable; Fus, fusidic acid resistance; Rif, rifampin resistance; Str, streptomycin resistance; Em, erythromycin resistance; Tc, tetracycline resistance; Tm, tobramycin resistance. The designation of the plasmid and its phenotypic characters are indicated. The tetracycline resistance is apparently chromosomal (see text).
tracts were prepared (7) and the enzymes were assayed by the phosphoceUlulose paper-binding technique (10) as described previously. The final concentration of aminoglycosides in the assay mixture was 66.7 ,ug/ml, and the reaction was allowed to proceed for 30 mim at 30°C.
DNA-DNA hybridization. DNA of plasmid pUB110 (22) originating from S. aureus (16) was purified by a tnodification of the procedure of Birnboim and Doly (1) , digested with HincII, and analyzed by agarose gel electrophoresis. The 473-base-pair (bp) HinclI fragment internal to aadC (20) was extracted, putified, and cloned into pUC8 that was digested with Hincll and dephosphorylated (18) . The resulting recombinant plasmid, pAT16, was digested with BamHI-PstI; and the 491-bp fragment containing part of aadC was extracted, purified (18) , and labeled with [a-32P]dATP by nick translation (19) . Dot blot hybridization under stringent conditions was done in 50% formamide at 42°C for 24 h, followed by three washings in 2x SSC (lx SSC is 0.15 M NaCl plus 0.015 M sodium citrate) at room temperature for 15 min and by two washings in 0.2x SSC at 65°C for 1 h.
Enzymes and chemicals. Restriction endonucleases were obtained from Boehringer GmbH (Mannheim, Federal Republic of Germany) and were used according to the recommendations of the manufacturer. Lysozyme was from Sigma Chemical Co. RNase A (bovine pancreas) and proteinase K were from Calbiochem-Behring (La Jolla, Calif.). [1-14C] Fig. 2 . Gentamicin A and B antibiotics, the kanamycin compounds, tobramycin, the neomycins, and butirosin were excellent substrates for the adenylyltransferase, whereas dibekacin, amikacin, paromomycin, and lividomycin were poor substrates. Gentamicins C, sisomicin, netilmicin, habekacin, apramycin, and fortimicin were not adenylylated. Based on this substrate profile and hybridization experiments (see below), the enzyme is a 4',4"-aminoglycoside nucleotidyltransferase [ANT(4')(4 '9] . BM4104 was transferred to a nitrocellulose filter and hybridized with a probe specific for aadC, the structural gene for ANT(4')(4') from S. aureus (Fig. 3) . Homology was found between the 473-bp fragment of pUB110 and total DNA of the strains harboring pIP810. DNA of pIP810 was hybridized to the same probe, and one HindIII and two EcoRI fragments of the plasmid displayed homology (Fig. 1) .
Influence of ANT(4')(4") on the bacteriostatic and bactericidal activities of aminoglycosides alone or combined with I8-lactams. There was a good correlation, except for amikacin, between the in vitro substrate range of the enzyme (Fig.  2) and the resistance phenotype of the host (Table 2) ; antibiotics which were good substrates (e.g., kanamycin, tobramycin, and neomycin) had very high MICs and antibiotics which were poor substrates (e.g., dibekacin) had moderately elevated MICs, whereas the MICs of aminoglycosides which were not detoxified (e.g., gentamicins C and habekacin) remained unchanged. By contrast, the bacteriostatic activity of amikacin apparently was not affected by the presence of the enzyme, although, as mentioned above, it was significantly modified by the cell extracts. This in vitro-in vivo discrepancy was studied further by determination, in liquid medium, of the MICs and MBCs of amikacin against isogenic strains that differed by the presence or the absence of the modifying activity. As in solid medium (Table  2) , the MICs of amikacin (128 ,ug/ml) were not altered by the presence of the enzyme, whereas the MBCs were dramatically increased (from 256 ,ug/ml for BM4110 to >2,048 jig/ml for BM4102 and BM4103).
The activities of combinations of penicillin with amikacin, kanamycin, and tobramycin were studied against the same pair of strains. The results are summarized in Table 3 , and Fig. 4 provides part of this analysis. As Substrate profiles of enzymes extracted from E. faecium BM4102 (spotted bars) and E. faecalis BM4103 (solid bars) assayed by the phosphocellulose paper-binding technique (10) . Adenylylation (average of three independent experiments) is expressed relative to that of tobramycin, which was set at 100%. No phosphorylation of the same aminoglycosides was detected in these strains, and no acetylation was detected in E. faecalis BM4103. No aminoglycoside-modifying activity was detected in the susceptible strain BM4110. E. faecium BM4102 and BM4105 produced low levels of 6'-aminoglycoside acetyltransferase (33) (data not shown). Abbreviations: Gen, gentamicin; Sis, sisomicin; Net, netilmicin; Kan, kanamycin; Tob, tobramycin; Dib, dibekacin; Ami, amikacin; Hab, habekacin; Neo, neomycin; Par, paromomycin; Liv, lividomycin; But, butirosin; Apr, apramycin; For, fortimicin.
resistance to kanamycin and tobramycin abolished the synergy with penicillin that these antibiotics display against susceptible strains. Most importantly, the synergism between penicillin and amikacin and the bactericidal activity of the combination were totally abolished by the presence of ANT(4')(4"). DISCUSSION E. faecium BM4102 was resistant to high levels of tobramycin and structurally related antibiotics but not to gentamicin ( mediated by pIP810, a 24.9-kilobase plasmid ( Fig. 1 ) that is self-transferable to other Enterococcus cells. Resistance to aminoglycosides was correlated with the presence of pIP810 DNA ( Fig. 1 and 3) . Plasmid-encoded, high-level resistance to aminoglycosides in enterococci-streptococci has been described previously (7, 11, 13, 25) . Resistance is frequently mediated by aminoglycoside-inactivating enzymes which are classified by the mechanism of their modification and the site of the antibiotic which they modify (4). High-level resistance to tobramycin not associated with resistance to gentamicin is novel in enterococci. We established, by in vitro substrate profile determination (Fig. 2) and DNA annealing studies (Figs. 1 and 3) , that resistance to tobramycin-kanamycin in BM4102 is due to the synthesis of a ANT(4')(4'3, an enzyme that has already been described in staphylococci (17) . The homology detected between pIP810 DNA and a probe specific for the ANT(4')(4") structural gene from staphylococci suggests that emergence of tobramycin-kanamycin resistance in enterococci is secondary to the acquisition of genetic information originating in staphylococci. This observation constitutes additional support for the notion that resistance genes are exchanged between these phylogenetically remote genera of pathogenic bacteria under natural conditions. The presence of the enzyme conferred to the host resistance toward the antibiotics that were substrates in vitro (Table 2 and Fig. 2) , with the exception of amikacin. Modification of the drug apparently did not affect the bacteriostatic activity of amikacin. However, the bactericidal activity of amikacin (Table 3 ) and the synergism of this aminoglycoside with penicillin (Fig. 4) were abolished. Similar pitfalls in the detection of plasmid-mediated resistance to amikacin and netilmicin, by synthesis of a 3'-phosphotransferase or the bifunctional enzyme 2"-phosphotransferase-6'-acetyltransferase, have been reported previously (2, 4, 29; Leclercq et al., in press). 
